De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Paysign Inkomsten in het verleden

Verleden criteriumcontroles 6/6

Paysign is de winst gegroeid met een gemiddeld jaarlijks percentage van 9.1%, terwijl de Diversified Financial industrie de winst jaarlijks groeide met 7.2%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 11.8% per jaar. Het rendement op eigen vermogen van Paysign is 28.8%, en het heeft een nettomarge van 14.4%.

Belangrijke informatie

9.1%

Groei van de winst

6.6%

Groei van de winst per aandeel

Diversified Financial Groei van de industrie	6.1%
Inkomstengroei	11.8%
Rendement op eigen vermogen	28.8%
Nettomarge	14.4%
Laatste winstupdate	30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

Opbrengsten en kosten

Hoe Paysign geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NasdaqCM:PAYS Opbrengsten, kosten en inkomsten (USD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
30 Jun 24	54	8	22
31 Mar 24	50	7	22
31 Dec 23	47	6	21
30 Sep 23	44	2	20
30 Jun 23	42	1	20
31 Mar 23	40	1	18
31 Dec 22	38	1	18
30 Sep 22	36	0	18
30 Jun 22	33	-1	17
31 Mar 22	31	-1	17
31 Dec 21	29	-3	16
30 Sep 21	28	-7	15
30 Jun 21	20	-13	15
31 Mar 21	20	-12	15
31 Dec 20	24	-9	15
30 Sep 20	27	-3	14
30 Jun 20	36	6	13
31 Mar 20	38	8	13
31 Dec 19	35	7	12
30 Sep 19	32	6	11
30 Jun 19	29	4	10
31 Mar 19	26	3	9
31 Dec 18	23	3	8
30 Sep 18	21	2	6
30 Jun 18	19	2	6
31 Mar 18	17	2	5
31 Dec 17	15	2	4
30 Sep 17	14	2	3
30 Jun 17	12	2	3
31 Mar 17	11	2	3
31 Dec 16	10	1	3
30 Sep 16	10	1	3
30 Jun 16	9	-2	3
31 Mar 16	9	-2	4
31 Dec 15	8	-2	4
30 Sep 15	11	0	4
30 Jun 15	11	3	3
31 Mar 15	9	2	3
31 Dec 14	10	3	3
30 Sep 14	7	0	2
30 Jun 14	7	0	2
31 Mar 14	7	0	2
31 Dec 13	6	1	1

Kwaliteitswinsten: PAYS heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (14.4%) PAYS } zijn hoger dan vorig jaar (3.1%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van PAYS is de afgelopen 5 jaar met 9.1% per jaar gegroeid.

Versnelling van de groei: De winstgroei van PAYS over het afgelopen jaar ( 494.1% ) overtreft het 5-jarig gemiddelde ( 9.1% per jaar).

Winst versus industrie: De winstgroei PAYS over het afgelopen jaar ( 494.1% ) overtrof de Diversified Financial -sector 10.5%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 28.8% ) van PAYS wordt als hoog beschouwd.

Paysign Inkomsten in het verleden

Verleden criteriumcontroles 6/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Recent updates

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improves as stock rises 34%

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

Price target decreased to US$3.44

Insufficient new directors

Price target decreased to US$3.44

Insufficient new directors

PaySign: A 'Backdoor' $2 Stagflation Play

Paysign: My Top Rebound Pick For 2022

Paysign: The Plasma Toll Booth

PaySign's Post-Pandemic Payoff

PaySign, Inc.(NasdaqCM:PAYS) dropped from Russell 2000 Defensive Index

PaySign, Inc. Provides Earnings Guidance for the Full Year 2021

Paysign, Inc. Announces Retirement of Joan M. Herman, as Chief Operating Officer

Why PaySign Is A Very Good Company

PaySign: Long-Term Story Still Intact

PaySign, Inc. and ImmunoTek Bio Centers LLC Collaborate in Support of COVID-19 Convalescent Plasma Collection